Biomedical Catalyst 2018 round 2: primer award

Fund Name: primer award
Project Length: 12-24 months
Project Value: Share of up to £5m
Deadline: 03/10/2018

Summary

The primer award supports a technical evaluation of your idea through to proof of concept in a model system, and can include:

  • experimental evaluation (at laboratory scale)
  • initial demonstration using in vitro and in vivo models (but not human clinical trials such as safety or efficacy)
  • exploring potential production mechanisms
  • early-stage prototyping
  • product development planning
  • intellectual property protection
Fund details

We support projects from any sector or discipline, including (but not limited to):

  • stratified healthcare (both therapeutic and diagnostic components)
  • advanced therapies (gene and cell therapies)
  • diagnostics
  • digital health
  • medical technologies and devices

If you choose the innovation area ‘Diagnostics, medical technology and devices’, please indicate within the scope whether your project falls within ‘Diagnostics’ or ‘Medical technology and devices’.

We expect projects to range in size from £200,000 to £1.5 million (total project costs). Projects should last 12 to 24 months and must start by 1 April 2019.

Eligibility

An SME business can:

  • take part in up to 3 applications in this competition round, although you may only be the lead partner in one application in this round
  • lead only one active project in any one Biomedical Catalyst award at any time

The exception to the rule on leading only one active project is when a new project is a direct progression from one award to the next category of awards. For example, you may already hold both an early stage and a late stage award. When the early stage project finishes, you may apply in this round for a late stage award to continue that specific programme of work while still holding your original late stage award. We will ask you to provide evidence that you have enough resources to run 2 projects at the same time.

If you applied to a previous competition as the lead or sole company and were awarded funding by Innovate UK, but you did not make a substantial effort to exploit that award, you will not be awarded more funding in this or any other competition. You will not be able to contest our decision. We will:

  • assess your efforts in the previous competition against your exploitation plan for that project
  • review the monitoring officers’ reports and any other relevant sources for evidence
  • document our decision, which will be made by 3 team members
  • communicate our decision to you in writing
Get in Touch

If you think that you might be eligible for this fund, please Get In Touch by filling out the contact form below.

Back to all funds